These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2109421)

  • 1. Effect of host immunomodulation on the prevention of islet allograft primary nonfunction in a murine model.
    Kaufman DB; Rabe FL; Platt JL; Dunn DL; Sutherland DE
    Transplant Proc; 1990 Apr; 22(2):857-8. PubMed ID: 2109421
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary nonfunction of human pancreatic islet xenografts is murine strain dependent.
    Carty SE; Carroll PB; Rilo H; Brumfield A; Ricordi C
    Transplant Proc; 1994 Apr; 26(2):780. PubMed ID: 8171660
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of antilymphocyte serum on crude pancreatic islet allograft survival.
    Gotoh M; Maki T; Satomi S; Porter J; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 1):576-7. PubMed ID: 3152704
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of concanavalin A on mouse islet cell transplantation.
    Zhu XY; He J; Yang PA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):954-6. PubMed ID: 3152647
    [No Abstract]   [Full Text] [Related]  

  • 5. Consistent long-term allograft survival in murine pancreatic islet transplants without immunosuppression.
    Jain K; Cai BR; Patel S; Yang H; Smith BH; Suthanthiran M; Rubin AL
    Transplant Proc; 1994 Dec; 26(6):3492-3. PubMed ID: 7998243
    [No Abstract]   [Full Text] [Related]  

  • 6. Interleukin-10 (IL-10) prevents primary nonfunction in allogeneic islet transplantation.
    Chao SH; Chu SH; Lee SC; Lin JK; Chen KM
    Transplant Proc; 1995 Feb; 27(1):602-4. PubMed ID: 7879114
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunomodulation with ionizing radiation does not prolong fish-to-mouse islet xenograft survival.
    Yang H; Kearns H; Wright JR
    Transplant Proc; 1995 Dec; 27(6):3312-3. PubMed ID: 8539966
    [No Abstract]   [Full Text] [Related]  

  • 8. Potent immunosuppressive effect of anti-LFA-1 monoclonal antibody on islet allograft rejection.
    Nishihara M; Gotoh M; Fukuzaki T; Ohta Y; Monden M; Yagita H; Okumura K; Miyasaka M; Mori T
    Transplant Proc; 1995 Feb; 27(1):372. PubMed ID: 7879025
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of mononuclear infiltrates in rejecting and surviving murine islet allografts.
    Serie JR; Goldberg JE; Pringle JA; Hegre OD
    Transplant Proc; 1990 Apr; 22(2):814-5. PubMed ID: 2109408
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of adhesion molecules in islet allo- and xenograft rejection.
    Gotoh M; Ohzato H; Fukuzaki T; Ohta Y; Nishihara M; Hasuike Y; Umeshita K; Sakon M; Yagita H; Okumura K; Miyasaka M; Monden M
    Transplant Proc; 1996 Apr; 28(2):617. PubMed ID: 8623304
    [No Abstract]   [Full Text] [Related]  

  • 11. Fifty islets maintain euglycemia and survive longer than 200 islets in allogeneic and xenogeneic diabetic hosts.
    Ohzato H; Porter J; Monaco AP; Maki T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):953-4. PubMed ID: 8442277
    [No Abstract]   [Full Text] [Related]  

  • 12. Permanent acceptance of mitomycin C-treated islet allograft.
    Matsuyama S; Gunji T; Ise K; Sato Y; Saito T; Gotoh M
    Transplantation; 2003 Jul; 76(1):65-71. PubMed ID: 12865788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islets of Langerhans rejection: allo vs xenotransplantation in animals.
    Bühler L; Deng S; Mage SR; Bubloz C; Rohner A; Morel P
    Transplant Proc; 1994 Apr; 26(2):764-5. PubMed ID: 8171653
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients.
    Desai NM; Bassiri H; Odorico JS; Koller BH; Smithies O; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1993 Feb; 25(1 Pt 2):961-2. PubMed ID: 8442280
    [No Abstract]   [Full Text] [Related]  

  • 15. Augmented survival of purified islet xeno- and allografts with reduced numbers.
    Gotoh M; Maki T; Porter J; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 2):984. PubMed ID: 3152654
    [No Abstract]   [Full Text] [Related]  

  • 16. IL-12p40 is not required for islet allograft rejection.
    Bi EG; Shi W; Zou J; Hao ZH; Li ZH; Cai D; Zhang HQ; Sun B
    Acta Pharmacol Sin; 2006 Aug; 27(8):1065-70. PubMed ID: 16867260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
    Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of islet allograft survival in mice treated with MHC class I specific F(ab')2 alloantibody.
    Osorio RW; Ascher NL; Melzer JS; Stock PG
    Transplant Proc; 1994 Apr; 26(2):749. PubMed ID: 8171642
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction.
    Nickerson P; Pacheco-Silva A; O'Connell PJ; Steurer W; Kelley VR; Strom TB
    Transplant Proc; 1993 Feb; 25(1 Pt 2):984-5. PubMed ID: 8442291
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of early loss of transplanted islets in the liver of mice by adenosine.
    Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y
    Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.